| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.ebnl.org | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 24.73 Cr. | |
| Earnings per share (EPS) | 2.90 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 17.07 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 35.25 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 11.41 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 4.34 | Calculated using Price: 49.50 |
| Dividend Yield | 0.00 | Period Ending 2020-03 |
| No. of Shares Subscribed | 0.50 Cr. | 4,996,100 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi . When there was a realisation that some of the Speciality Chemicals developed in our R&D and exported to USA & Europe were being used in Healthcare formulations, the Company decided to re-orient itself and enter the Healthcare business, which is poised for phenomenal growth in the coming decades. Concurrently the company also realised that some of the Speciality Chemicals are actually Vital Micro Nutrients, which are being used in the research worldwide as tools of Biotechnology, the Company took a conscious decision to enter the field of Biotechnology & Healthcare. To ensure that the name is representative of its activity, the company's name was changed from Emmessar Chemical Industries Ltd., to Emmessar Biotech & Nutrition Ltd., on 7th April 2000. In the process of pursuing its own R&D and exploring commercial market potentials for their products in the field of Healthcare, the company came across another reputed company in USA Vibrant Life in California. Intense exchange of ideas & technical information between Emmessar Biotech & Nutrition Ltd., & Vibrant Life, resulted in development of several new concepts and new technologies - combining different schools of thought such as Nutraceuticals, Cosmeceuticals, Ayurveda & Biotechnology. The company has developed many products covering different areas of healthcare that include obstinate Skin problems & debilitating chronic physical ailments. Emmessar Biotech & Nutrition Ltd., is a Public Limited Company, with the Paid-up Share Capital of about Rs. 50.00 million (over $ 1.00 million). The Stocks of Emmessar Biotech & Nutrition Ltd., are traded in The Bombay Stock Exchange Ltd. Product range of the company includes: Present products
Products planned to be launched in future
|
||
Company Profile
Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .
When there was a realisation that some of the Speciality Chemicals developed in our R&D and exported to USA & Europe were being used in Healthcare formulations, the Company decided to re-orient itself and enter the Healthcare business, which is poised for phenomenal growth in the coming decades.
Concurrently the company also realised that some of the Speciality Chemicals are actually Vital Micro Nutrients, which are being used in the research worldwide as tools of Biotechnology, the Company took a conscious decision to enter the field of Biotechnology & Healthcare.
To ensure that the name is representative of its activity, the company's name was changed from Emmessar Chemical Industries Ltd., to Emmessar Biotech & Nutrition Ltd., on 7th April 2000.
In the process of pursuing its own R&D and exploring commercial market potentials for their products in the field of Healthcare, the company came across another reputed company in USA Vibrant Life in California.
Intense exchange of ideas & technical information between Emmessar Biotech & Nutrition Ltd., & Vibrant Life, resulted in development of several new concepts and new technologies - combining different schools of thought such as Nutraceuticals, Cosmeceuticals, Ayurveda & Biotechnology.
The company has developed many products covering different areas of healthcare that include obstinate Skin problems & debilitating chronic physical ailments.
Emmessar Biotech & Nutrition Ltd., is a Public Limited Company, with the Paid-up Share Capital of about Rs. 50.00 million (over $ 1.00 million). The Stocks of Emmessar Biotech & Nutrition Ltd., are traded in The Bombay Stock Exchange Ltd.
Product range of the company includes:
Present products
Products planned to be launched in future
| 1 Day |
|
+4.98% |
| 1 Week |
|
+9.76% |
| 1 Month |
|
+17.72% |
| 3 Month |
|
+133.38% |
| 6 Month |
|
+181.25% |
| 1 Year |
|
+268.30% |
| 2 Year |
|
+280.77% |
| 5 Year |
|
+216.29% |
| 9 years | 2012-03 | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | -1.25 | -9.32 | -17.71 | -7.98 | -40.75 | 78.73 | 36.00 | 16.42 | 19.40 | |
| Return on Capital Employed (%) | -1.12 | -9.22 | -9.52 | -10.49 | -59.37 | 79.46 | 31.46 | 9.00 | 18.87 | |
| Return on Assets (%) | -0.55 | -3.73 | -8.60 | -5.08 | -20.32 | 44.83 | 26.93 | 12.75 | 14.93 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 2 | 2 | 2 | 1 | 1 | 2 | 3 | 4 | 4 | |
| Non Curr. Liab. | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | ||
| Curr. Liab. | 3 | 3 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | |
| Minority Int. | ||||||||||
| Equity & Liab. | 5 | 5 | 2 | 2 | 2 | 3 | 4 | 5 | 5 | |
| Non Curr. Assets | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | |
| Curr. Assets | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | |
| Misc. Exp. not W/O | ||||||||||
| Total Assets | 5 | 5 | 2 | 2 | 2 | 3 | 4 | 5 | 5 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 3 | 1 | 1 | 2 | 2 | 3 | 1 | 1 | 3 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | |
| Total Income | 3 | 1 | 1 | 2 | 2 | 4 | 3 | 2 | 5 | |
| Total Expenditure | -3 | -1 | -1 | -2 | -2 | -2 | -2 | -1 | -4 | |
| PBIDT | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | |
| Interest | 0 | |||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Exceptional Items | -1 | 0 | 0 | |||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | ||
| Cash Fr. Inv. | 0 | 0 | 0 | -1 | -1 | 0 | -1 | |||
| Cash Fr. Finan. | ||||||||||
| Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Thu, 22 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to the provisions of Regulation 47(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the newspaper clippings regarding the intimation of Board Meeting to be held on Thursday July 29 2021 published in The Free Press Journal in English and Navshakti in Marathi dated 21-07-2021 are attached. You are kindly requested to take this on record. |
|
Mon, 19 Jul 2021
Intimation Under 30 SEBI (LODR) 2015 Pursuant to Regulation 31A (8) (a) of the SEBI (LODR) 2015 please be informed that requests have been received from constituents of Promoter / Promoter Group as per details attached for re-classification of their shareholding into Public shareholding. Since there is a cleavage on this aspect these applicants have been informed to obtain informal guidance from SEBI under the SEBI (Informal Guidance) Scheme 2003. |
|
Mon, 19 Jul 2021
Board Meeting Intimation for Notice Of The Meeting Of Board Of Directors Of The Company Under Regulation 29(1)(A) Of SEBI (LODR) Regulations 2015.<BR> EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2021 inter alia to consider and approve the Un-Audited Financial Results of the Company for the quarter ended 30.06.2021 which will be subjected to Limited Review. To discuss any other matter as may be decided by the Board. |
| Mon, 26 Jul 2021 |
Stock Outperforming Benchmark Index in both 1 Week and 3 Month
|
Stock Outperforming Sectoral Index in both 1 Week and 3 Month
|
Strongly Outperforming Benchmark Index
|
Increasing Relative Strength - Benchmark index
|
Strongly Outperforming Sectoral Index
|
Equities
M.F.
Sectors